No abstract available
MeSH terms
-
Apoptosis / drug effects
-
B-Lymphocytes / drug effects*
-
B-Lymphocytes / metabolism
-
B-Lymphocytes / pathology
-
Crotonates / pharmacology
-
Cyclin A / metabolism
-
Cyclin D3
-
Cyclin-Dependent Kinase 2 / antagonists & inhibitors
-
Cyclins / metabolism
-
DNA Replication / drug effects
-
Dihydroorotate Dehydrogenase
-
Drug Screening Assays, Antitumor
-
G1 Phase / drug effects*
-
Humans
-
Hydroxybutyrates
-
Immunologic Factors / pharmacology*
-
Isoxazoles / pharmacology*
-
Leflunomide
-
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
-
Neoplasm Proteins / antagonists & inhibitors
-
Nitriles
-
Oxidoreductases Acting on CH-CH Group Donors / antagonists & inhibitors
-
Phosphorylation / drug effects
-
Prodrugs / pharmacology
-
Protein Processing, Post-Translational / drug effects
-
Receptors, Immunologic / antagonists & inhibitors
-
Receptors, Prostaglandin / antagonists & inhibitors
-
Retinoblastoma Protein / metabolism
-
Toluidines / pharmacology
-
Tumor Cells, Cultured / drug effects
-
ZAP-70 Protein-Tyrosine Kinase / analysis
Substances
-
CCND3 protein, human
-
Crotonates
-
Cyclin A
-
Cyclin D3
-
Cyclins
-
Dihydroorotate Dehydrogenase
-
Hydroxybutyrates
-
Immunologic Factors
-
Isoxazoles
-
Neoplasm Proteins
-
Nitriles
-
Prodrugs
-
Receptors, Immunologic
-
Receptors, Prostaglandin
-
Retinoblastoma Protein
-
Toluidines
-
teriflunomide
-
Oxidoreductases Acting on CH-CH Group Donors
-
ZAP-70 Protein-Tyrosine Kinase
-
ZAP70 protein, human
-
CDK2 protein, human
-
Cyclin-Dependent Kinase 2
-
Leflunomide
-
prostaglandin D2 receptor